[Raynaud's phenomenon; diagnosis and treatment]. diagnostiek en behandeling.

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Primary Raynaud's phenomenon (RP) is a relatively common disorder. Most patients with primary RP have only mild symptoms and do not develop complications. Distinguishing primary from secondary RP is important with respect to complications, and for prognosis and treatment. Secondary RP mainly manifests as part of systemic connective tissue disease. About 13% of patients diagnosed initially as having primary RP develop a systemic disorder within the following few years. Both auto-immune serology including antinuclear antibodies (ANA), and capillaroscopy are important diagnostic tools if one suspects the existence or development of a systemic disorder. Calcium antagonists are the cornerstone of RP pharmacotherapy.

Translated title of the contribution[Raynaud's phenomenon; diagnosis and treatment].
Original languageDutch
JournalNederlands Tijdschrift voor Geneeskunde
Volume153
Publication statusPublished - 1 Dec 2009

Cite this

@article{eb54a8ac0fe145b699dfb28955055532,
title = "Het fenomeen van Raynaud: diagnostiek en behandeling.",
abstract = "Primary Raynaud's phenomenon (RP) is a relatively common disorder. Most patients with primary RP have only mild symptoms and do not develop complications. Distinguishing primary from secondary RP is important with respect to complications, and for prognosis and treatment. Secondary RP mainly manifests as part of systemic connective tissue disease. About 13{\%} of patients diagnosed initially as having primary RP develop a systemic disorder within the following few years. Both auto-immune serology including antinuclear antibodies (ANA), and capillaroscopy are important diagnostic tools if one suspects the existence or development of a systemic disorder. Calcium antagonists are the cornerstone of RP pharmacotherapy.",
author = "Hofstee, {Herman M.A.} and Voskuyl, {Alexandre E.} and Sern{\'e}, {Erik H.} and Smulders, {Yvo M.}",
year = "2009",
month = "12",
day = "1",
language = "Dutch",
volume = "153",
journal = "Nederlands Tijdschrift voor Geneeskunde",
issn = "0028-2162",
publisher = "Bohn Stafleu van Loghum",

}

Het fenomeen van Raynaud : diagnostiek en behandeling. / Hofstee, Herman M.A.; Voskuyl, Alexandre E.; Serné, Erik H.; Smulders, Yvo M.

In: Nederlands Tijdschrift voor Geneeskunde, Vol. 153, 01.12.2009.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Het fenomeen van Raynaud

T2 - diagnostiek en behandeling.

AU - Hofstee, Herman M.A.

AU - Voskuyl, Alexandre E.

AU - Serné, Erik H.

AU - Smulders, Yvo M.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Primary Raynaud's phenomenon (RP) is a relatively common disorder. Most patients with primary RP have only mild symptoms and do not develop complications. Distinguishing primary from secondary RP is important with respect to complications, and for prognosis and treatment. Secondary RP mainly manifests as part of systemic connective tissue disease. About 13% of patients diagnosed initially as having primary RP develop a systemic disorder within the following few years. Both auto-immune serology including antinuclear antibodies (ANA), and capillaroscopy are important diagnostic tools if one suspects the existence or development of a systemic disorder. Calcium antagonists are the cornerstone of RP pharmacotherapy.

AB - Primary Raynaud's phenomenon (RP) is a relatively common disorder. Most patients with primary RP have only mild symptoms and do not develop complications. Distinguishing primary from secondary RP is important with respect to complications, and for prognosis and treatment. Secondary RP mainly manifests as part of systemic connective tissue disease. About 13% of patients diagnosed initially as having primary RP develop a systemic disorder within the following few years. Both auto-immune serology including antinuclear antibodies (ANA), and capillaroscopy are important diagnostic tools if one suspects the existence or development of a systemic disorder. Calcium antagonists are the cornerstone of RP pharmacotherapy.

UR - http://www.scopus.com/inward/record.url?scp=79958117727&partnerID=8YFLogxK

M3 - Review article

VL - 153

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

SN - 0028-2162

ER -